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OBJECTIVES We sought to study the prevalence and mortality of subjects exhibiting the Brugada-type
electrocardiogram (ECG) in a community-based population in Japan.
BACKGROUND The Brugada syndrome has been associated with sudden death in subjects without structural
heart disease. Hospital-based studies showed 11% to 38% annual fatal arrhythmic events in
patients with the Brugada syndrome.
METHODS Prevalence and mortality of the Brugada-type ECG were studied in subjects who had ECGs
during a health examination in Moriguchi, Osaka, Japan. Information about death and
relocation from Moriguchi city was obtained prospectively.
RESULTS The Brugada-type ECG was found in 98 of 13,929 study subjects (0.70%, 95% confidence
interval [CI]: 0.57% to 0.86%). The typical coved-type with an rsR9 pattern in V1 lead
(“typical” Brugada-type) was found in 0.12% of subjects (95% CI: 0.07% to 0.20%). The
prevalence for male subjects with the Brugada-type ECG (81%) was significantly higher than
it was for those without (26%, p , 0.0001). In male subjects, the Brugada-type ECG was
found in 2.14% (95% CI: 1.70% to 2.66%), and the “typical” Brugada-type was found in
0.38% (95% CI: 0.21% to 0.64%). After 2.6 6 0.3 years of follow-up, there was 1 death
(1.0%, 95% CI: 0.03% to 5.6%) of a subject with the Brugada-type ECG, whereas there were
139 deaths (1.0%, 95% CI: 0.85% to 1.2%) of those without the Brugada-type ECG (p 5
0.9943, log-rank test).
CONCLUSIONS A substantial number of the Brugada-type ECG were observed in subjects in a community-
based population in Japan, especially in men. The total mortality of subjects with the
Brugada-type ECG did not differ from the mortality of those without the Brugada-type ECG
in a community-based population. (J Am Coll Cardiol 2001;38:771–4) © 2001 by the
American College of Cardiology
In 1992, Brugada et al. (1) first reported a specific electro-
cardiogram (ECG) pattern of right bundle-branch block
and ST-segment elevation in leads V1, V2 to V3 associated
with sudden death in patients without demonstrable struc-
tural heart disease. Several reports have been published
about this syndrome in various populations (2–8). Previous
observations demonstrated that patients with the Brugada-
type ECG were at high risk for fatal arrhythmic events of
11% to 38% annually in a hospital-based population (3–5).
See page 775
However, there are few data available on the mortality of
subjects with the Brugada-type ECG in a community-based
population.
We studied the prevalence of the Brugada-type ECG in
a community-based population in Japan and prospectively
examined whether this sign was associated with an increased
mortality.
METHODS
Study subjects. Our study population consisted of subjects
who had ECGs during a health examination for adult
citizens in Moriguchi, Osaka, Japan, in 1997.
The city of Moriguchi is representative of a mid-sized
urban city in Japan. At the time of our study, the population
in the city of Moriguchi was about 156,300, 49% of the
population were men, and approximately 77,100 of the total
population were $40 years old. The city of Moriguchi
offered annual health examinations for adult citizens who
had not received a health examination from their company
or organization. Most of the subjects in our study popula-
tion were $40 years old. Although all subjects $40 years
old who received the health examination in Moriguchi had
an ECG recording, ECG recording was limited to subjects
who were suspected to have a cardiac abnormality during
their physical examination, if the subject was ,40 years old.
There were 85 of 13,929 total study subjects who were ,40
years old. Of those, 1 subject had the Brugada-type ECG
and no one died during follow-up period.
Definition and diagnosis of the Brugada-type ECG. All
ECGs were recorded at standard gain (1 mV/10 mm) and
paper speed (25 mm/s). An ECG was considered to be a
Brugada-type ECG when the 12-lead ECG with right
bundle-branch block (rsR9 or Rsr9 pattern in V1 lead) and
ST-segment elevation in the right precordial leads looked
From the Cardiovascular Division, Department of Medicine II, Kansai Medical
University, Osaka, Japan.
Manuscript received January 5, 2001; revised manuscript received April 5, 2001,
accepted May 17, 2001.
Journal of the American College of Cardiology Vol. 38, No. 3, 2001
© 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00
Published by Elsevier Science Inc. PII S0735-1097(01)01419-X
like the ECGs shown in the figures of the original publi-
cation by Brugada et al. (1). We also used ECG character-
istics of our own to diagnose patients with definite Brugada
syndrome. ST-segment elevation was defined as an eleva-
tion of the J point of $0.1 mV in leads V1 to V2 to V3.
According to the configuration, ST-segment elevations
were designated as either coved or saddleback (Fig. 1).
To diagnose Brugada-type ECG, we (Y.M. and H.T.)
examined ECGs without any information about the subject
including age, gender, or medical history. Diagnosis of the
Brugada-type ECG was made when both investigators
considered an ECG to be the Brugada-type ECG.
To compare the prevalence of the Brugada-type ECG
with recent reports of healthy populations, we defined the
“typical” Brugada-type ECG, which only included an rsR9
pattern in the V1 lead with the ST-segment elevation of a
coved-type ECG.
Outcome event and follow-up. The outcome event was
all-cause mortality. Information about death and relocation
from Moriguchi city was obtained prospectively from the
city residents’ record.
Statistical analysis. Interobserver agreement was deter-
mined by overall proportion of agreement and the Kappa
statistic. Confidence intervals (CI) of the binomial distri-
bution for the prevalence rates were calculated. Fisher’s
exact test was used to test the difference in prevalence rate.
The log-rank test was used for comparison of the difference
in mortality between the subjects with and without the
Brugada-type ECG. All calculations were performed by the
Statistical Analysis System version 6.12. Values were ex-
pressed as the mean 6 SD. A p value of ,0.05 was
considered statistically significant.
RESULTS
Our study population consisted of 13,929 subjects with a
mean age of 58 6 10 years, 26.5% of the population were
men (n 5 3,691). One investigator (Y.M.) found 104
ECGs to be the Brugada-type, and another investigator
(H.T.) found 133 ECGs to be the Brugada-type. Of those,
there were 98 ECGs (0.70%, 95% CI: 0.57% to 0.86%) that
both investigators considered to be the Brugada-type ECG.
The overall proportion of agreement was 99.7% with the
Kappa score of 0.824.
Subjects with the Brugada-type ECG had a similar mean
age (58 6 9 years) to that of those without (58 6 10 years).
The prevalence of male subjects with the Brugada-type
ECG (81%) was significantly higher than that of those
without (26%, p , 0.0001). In the Brugada-type ECG, the
coved-type ST-segment elevation was found in 38% of the
subjects, and the rsR9 pattern in the V1 lead was found in
41% of the subjects. The “typical” Brugada-type ECGs with
the coved-type ST-segment elevation and rsR9 pattern in
the V1 lead were found in 17 subjects (0.12%, 95% CI:
0.07% to 0.20%) (Table 1). In male subjects, the Brugada-
type ECG was found in 2.14% (95% CI: 1.7% to 2.66%),
and the “typical” Brugada-type ECG was found in 0.38%
(95% CI: 0.21% to 0.64%).
During 2.6 6 0.3 years of follow-up, 2.7% of subjects
without the Brugada-type ECG and 2.0% of subjects with
the Brugada-type ECG relocated from Moriguchi city (p 5
1.000). There was 1 death among the 98 subjects (1.0%,
95% CI: 0.03% to 5.6%) with the Brugada-type ECG,
whereas there were 139 deaths of 13,831 subjects (1.0%,
95% CI: 0.85% to 1.2%) without the Brugada-type ECG
(Fig. 2). The log-rank test showed no significant difference
in all-cause mortality between subjects with and without the
Brugada-type ECG (p 5 0.9943). The subject who died
with the Brugada-type ECG was a 56-year-old man. He
had a saddleback ST-segment elevation and died suddenly.
There was no information about his history of syncope or
family history of sudden death.
DISCUSSION
Prevalence of the Brugada-type ECG. Tohyou et al. (6)
reported a 0.07% prevalence of the Brugada-type ECG in
4,092 healthy Japanese adult subjects. In their criteria of the
Brugada-type ECG, the saddleback-type ST-segment ele-
vation and Rsr9 pattern in the V1 lead were excluded.
Hermida et al. (8) reported one subject with the Brugada-
type ECG with the typical coved-type ST-segment eleva-
tion and rsR9 pattern in V1 of 1,000 apparently healthy
subjects (0.1%) (8). Viskin et al. (7) reported there were no
patients with the “definite” Brugada-type ECG based on
Abbreviations and Acronyms
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Figure 1. Examples of the ST-segment elevations of coved and saddleback
type. Left panel shows the ST-segment elevation of coved type. Right
panel shows the ST-segment elevation of saddleback type.
Table 1. The Brugada-type ECG and the “Typical” Brugada-
Type ECG
ST-Segment Elevation
Lead V1 Coved Saddleback Total
rsR9 17* 23 40 (41%)
Rsr9 20 38 58 (59%)
Total 37 (38%) 61 (62%) 98 (100%)
*“Typical” Brugada-type ECG.
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their definition in 592 healthy control patients (0%) referred
to their hospital. Monroe et al. (9) reported 52 subjects with
the Brugada-type ECG including saddleback-type and the
coved-type ST-segment elevation out of approximately
12,000 noncardiac patients. However, in their report, de-
mographic data of their study subjects such as age or gender
were not available (9). In this study, the “typical” Brugada-
type with the coved-type ST-segment elevation and rsR9
pattern in the V1 lead was found in 0.12% of the subjects.
These results were fairly similar suggesting that the preva-
lence of the “typical” Brugada-type ECG in a healthy
population would be 0.11% (Table 2). Since our study
population predominantly consisted of women, sex specific
prevalence of the “typical” Brugada-type ECG is also
presented in Table 2. An estimated prevalence of the
“typical” Brugada-type ECG was 0.23% in men. In this
analysis, the prevalence of the “typical” Brugada-type ECG
was observed about eight times more frequently in men than
it was in women.
We originally included the saddleback-type ST-segment
elevation or Rsr9 pattern in V1 because the original publi-
cation of the Brugada syndrome (1) and other publications
(7) considered the saddleback-type ST-segment elevation as
the Brugada-type ECG, and it is well known that ST-
segment elevation of the Brugada-type ECG changes into a
saddleback from a coved-type (3). As a result, the Brugada-
type ECG, as originally defined, was found in 0.70% with a
95% CI of 0.57% to 0.86% in a community-based popula-
tion in Japan.
Mortality of the Brugada-type ECG. The previous ob-
servations demonstrated that patients with the Brugada-
type ECG were at high risk for sudden death (11% to 38%
per year), and sudden death was associated with syncope or
family history of sudden death (3–5,10). However, these
observations were studied in a hospital-based population.
We studied a community-based population in Japan.
Brugada et al. (5) reported 22 individuals who were
asymptomatic when their Brugada sign was recognized
incidentally or after diagnosis of a symptomatic relative. Six
of them eventually had arrhythmic events (27%, 95% CI:
11% to 50%) during a mean follow-up of 34 months (5).
However, 9 of 22 asymptomatic individuals were detected
because they had a family history of sudden death. Although
one subject, a 56-year-old man with the saddleback-type
ST-segment elevation, died suddenly in our study, total
mortality of subjects with the Brugada-type ECG did not
differ from those without. An estimated upper limit during
a mean follow-up of 2.6 years was 5.6%. This result was
consistent with the observations of a few previous reports
about asymptomatic subjects with the Brugada-type ECG
(3,10–12).
Conclusions. We conclude that a Brugada-type ECG may
be found in a substantial number of people, especially men.
The mortality of subjects with the Brugada-type ECG did
not differ from that of subjects without the Brugada-type
ECG in a community-based population. We suggest that
mortality of the Brugada-type ECG in a community-based
Figure 2. Comparison of all-cause mortality between subjects with and without the Brugada-type electrocardiogram (ECG) during 2.6 6 0.3 years of
follow-up period. CI 5 confidence interval.
Table 2. Comparison of the Prevalance of the “Typical” Brugada-Type ECG in Healthy Populations
Reference Total Subjects Mean Age (yr) Men
Prevalence (95% CI)
Total Men Women
Present study 13,929 58 6 10 27% 0.12% (0.07, 0.20) 0.38% (0.21, 0.64) 0.03% (0.01, 0.09)
Tohyou et al. (6) 4,092 46* 78% 0.07% (0.02, 0.21) 0.09% (0.02, 0.27) 0.00% (0.00, 0.41)
Viskin et al. (7) 592 36 6 10 58% 0.00% (0.00, 0.62) 0.00% (0.00, 1.06) 0.00% (0.00, 1.50)
Hermida et al. (8) 1,000 39 6 10 63% 0.10% (0.00, 0.56) 0.16% (0.00, 0.88) 0.00% (0.00, 1.00)
Overall 19,613 0.11% (0.07, 0.16) 0.23% (0.14, 0.36) 0.03% (0.01, 0.08)
*No data of standard deviation.
CI 5 confidence interval.
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population is much lower than the mortality seen in a
hospital-based population, as previously reported.
Study limitations. The contour of the ST segment has
been reported to change. Although we included subjects
with saddleback ST-segment elevation, it is still likely to
underestimate the prevalence of the Brugada-type ECG.
Our mean follow-up period of 2.6 years was not long
enough. However, there have been no studies to evaluate
mortality of Brugada-type ECG in a community-based
sample in this number of subjects. Moreover, no study has
compared the mortality between subjects with and without
the Brugada-type ECG. In our study, only 27% of the
population were men. However, our study subjects still
included 3,691 men. Our study subjects were mainly older
than 40 years. Mean ages of patients with reported Brugada
syndrome were 40 to 50 years (3–5). The prognosis of the
Brugada-type ECG in a patient less than 40 years old was
not included in this study. Repetitive ECG recordings with
younger subjects and long-term follow-up should be con-
sidered in future studies.
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